We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$96.7B
AUM Growth
-$4.91B
(-4.8%)
Cap. Flow
-$19.4B
Cap. Flow
% of AUM
-20.03%
Top 10 Holdings %
Top 10 Hldgs %
24.57%
Holding
2,878
New
61
Increased
764
Reduced
1,806
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$300M |
| 3 |
PayPal
PYPL
|
+$241M |
| 4 |
Intuitive Surgical
ISRG
|
+$232M |
| 5 |
HPE.PRC
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$874M |
| 2 |
Amazon
AMZN
|
+$807M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$667M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
ASML
ASML
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.93% |
| 2 | Healthcare | 9.84% |
| 3 | Consumer Discretionary | 8.91% |
| 4 | Financials | 8.66% |
| 5 | Industrials | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSVT
2576
DELISTED
2seventy bio
TSVT
| $77.9K | ﹤0.01% |
16,510
-124
| -0.7% | -$559 |
|
2577
Fulcrum Therapeutics
FULC
$284M
| $77.4K | ﹤0.01% |
21,671
+517
| +2% | +$3.84K |
|
|
BHR
2578
Braemar Hotels & Resorts
BHR
$140M
| $77.2K | ﹤0.01% |
24,993
+31
| +0.1% | +$97 |
|
2579
James River Group Holdings
JRVR
$199M
| $76.7K | ﹤0.01% |
12,235
-369
| -3% | -$2.71K |
|
2580
Lyell Immunopharma
LYEL
$354M
| $76.6K | ﹤0.01% |
2,777
-152
| -5% | -$4.47K |
|
2581
LanzaTech
LNZA
$69M
| $76.1K | ﹤0.01% |
399
| – | – |
|
2582
Omeros
OMER
$979M
| $75.5K | ﹤0.01% |
19,016
-443
| -2% | -$1.89K |
|
2583
Prime Medicine
PRME
$582M
| $74.2K | ﹤0.01% |
19,184
| – | – |
|
2584
Trevi Therapeutics
TRVI
$2.54B
| $74.2K | ﹤0.01% |
22,222
-212
| -0.9% | -$630 |
|
2585
Sight Sciences
SGHT
$452M
| $74K | ﹤0.01% |
11,742
-366
| -3% | -$2.46K |
|
|
MRSN
2586
DELISTED
Mersana Therapeutics
MRSN
| $72.4K | ﹤0.01% |
1,532
-12
| -0.8% | -$529 |
|
|
TPIC
2587
DELISTED
TPI Composites
TPIC
| $72.2K | ﹤0.01% |
15,875
+295
| +2% | +$1.21K |
|
2588
Solid Power
SLDP
$543M
| $72K | ﹤0.01% |
53,325
-2,106
| -4% | -$3.33K |
|
2589
Wheels Up
UP
$188M
| $71.6K | ﹤0.01% |
1,479
-50
| -3% | -$2.44K |
|
2590
Destination XL Group
DXLG
$32.2M
| $71.5K | ﹤0.01% |
24,324
+1,186
| +5% | +$3.69K |
|
|
PSTX
2591
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $71.3K | ﹤0.01% |
24,945
+318
| +1% | +$984 |
|
2592
Organogenesis Holdings
ORGO
$229M
| $71K | ﹤0.01% |
24,836
| – | – |
|
2593
Custom Truck One Source
CTOS
$2.48B
| $70.8K | ﹤0.01% |
20,531
+215
| +1% | +$904 |
|
2594
Atossa Therapeutics
ATOS
$23.6M
| $70.5K | ﹤0.01% |
3,090
| – | – |
|
2595
Cabaletta Bio
CABA
$455M
| $70.3K | ﹤0.01% |
14,904
+611
| +4% | +$3.54K |
|
2596
Monte Rosa Therapeutics
GLUE
$1.37B
| $69.5K | ﹤0.01% |
13,122
+1,969
| +18% | +$9.94K |
|
2597
iHeartMedia
IHRT
$452M
| $69.5K | ﹤0.01% |
37,581
+125
| +0.3% | +$186 |
|
|
NVRO
2598
DELISTED
NEVRO CORP.
NVRO
| $69.5K | ﹤0.01% |
12,433
| – | – |
|
2599
Compass Therapeutics
CMPX
$394M
| $69.3K | ﹤0.01% |
37,663
+8,974
| +31% | +$11.2K |
|
2600
TScan Therapeutics
TCRX
$50.4M
| $69.3K | ﹤0.01% |
13,911
+308
| +2% | +$1.86K |
|
Similar funds
VAM
VOYA Investment Management's Q3 2024 Portfolio in Review
As of Q3 2024, VOYA Investment Management held 2,878 positions worth $96.7B, down 4.8% from $102B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
VOYA Investment Management withdrew a net $19.4B in Q3 2024, closing 67 positions and reducing 1,806 holdings. Its most notable exit was Vanguard Short-Term Corporate Bond ETF, an estimated $80.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, VOYA Investment Management opened a new position in Hewlett Packard Enterprise 7.625% Series C Preferred Stock worth $208M.
- VOYA Investment Management's largest Q3 2024 buy was Hewlett Packard Enterprise 7.625% Series C Preferred Stock: 3,432,500 shares worth $208M.
- VOYA Investment Management added most to UnitedHealth in Q3 2024, an estimated $363M increase.
- VOYA Investment Management's biggest Q3 2024 reduction was Apple, cutting an estimated $874M.
- VOYA Investment Management fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2024, selling an estimated $80.7M.
- VOYA Investment Management's ten largest holdings make up 25% of its $96.7B portfolio in Q3 2024.
- VOYA Investment Management opened 61 new positions and closed 67 in Q3 2024.
- VOYA Investment Management's portfolio value fell 4.8% quarter-over-quarter to $96.7B.
Based on VOYA Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.